Patent ID: 11951115
Assignee: UNITY BIOTECHNOLOGY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 25:
26. The method of claim 14, wherein the patient demonstrates an improvement of between 5-7 ETDRS letter improvement on BCVA over baseline, of between 6-8 ETDRS letter improvement on BCVA over baseline, of between 7-9 ETDRS letter improvement on BCVA over baseline, of between 10-15 ETDRS letter improvement on BCVA over baseline, of between 15-20 ETDRS letter improvement on BCVA over baseline, of between 20-25 ETDRS letter improvement on BCVA over baseline, of between 25-30 ETDRS letter improvement on BCVA over baseline.